Our newly generated discriminatory anti-CR1/anti-CR3 monoclonal antibodies have now proven that CR3 is a translated protein found in diverse human cancers, tracking with disease severity, involved with cell signaling and expressed as a cell-tethered or soluble entity, thus negating its pseudogene status. The gene discussed is CR1; the disease is cancer.